Newsfile Corp
16 Nov 2026, 09:30 UTC · 16h ago
Kaplan Fox is Investigating Madrigal Pharmaceuticals, Inc. (MDGL) on Behalf of Investors for Potential Securities Law Violations
Impact · against what's priced in
Madrigal Pharmaceuticals faces potential downward pressure as a legal investigation into securities law violations introduces new regulatory and litigation risk. This creates a possible overhang on the stock multiple ahead of potential class-action filings.
- MDGL−0.30
No priced-in read yet





